Federal award
TEVA PHARMACEUTICALS USA, INC.
W81XWH20C0100
Contract
Obligated and Ceiling
- Obligated (net)
- $928,807.39
- Ceiling (potential value, not spending)
- $969,614.00
- Current value
- $969,614.00
- Gross positive obligations
- $969,614.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- TEVA PHARMACEUTICALS USA, INC. · NEN9A34LRHJ5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- TEVA PHARMACEUTICALS USA, INC. · NEN9A34LRHJ5
- Awarding agency
- Department of War · sub-agency 97DH · office HT9425
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- AN95 · R&D- MEDICAL: OTHER (OPERATIONAL SYSTEMS DEVELOPMENT)
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W81XWH20C0100
- Award type code
- D
- Actions
- 2 · Aug 5, 2020 to Jan 22, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History2
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 22, 2025 | FY2025 | P00001 | K | −$40,806.61 | — |
| Aug 5, 2020 | FY2020 | 0 | — | $969,614.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.